Cannae (CNNE) director awarded 7,818 RS; holdings now 28,818
Cannae Holdings (CNNE) reported an insider equity award.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cannae Holdings (CNNE) reported an insider equity award. A director acquired 7,818 shares of common stock on 11/12/2025 at a reported price of $0, reflecting a restricted stock grant. Following the transaction, the director’s beneficial ownership stands at 28,818 shares.
The award vests in three equal annual installments beginning November 12, 2026, aligning compensation with longer-term service. This filing documents the grant and updated holdings; it does not indicate any open-market purchase or sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 7,818 | $0.00 | $0.00 |
Footnotes (1)
- F1. Grant of restricted stock vesting in three equal annual installments beginning November 12, 2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Cannae Holdings (CNNE) disclose in this Form 4?
What is the vesting schedule for the restricted stock?
Was this an open-market transaction?
What is the title of security involved in the transaction?
Is there any derivative security reported in this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.